The U.S. Food and Drug Administration proposed on Monday a new framework to speed approvals of personalized treatments for ...
After dumping its sole remaining gene therapy asset last year, Pfizer has decided to exercise its option for global rights to Beam Therapeutics’ liver-targeted gene editing candidate.
Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...
The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would ...
Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...
Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...
Despite innovative new research, many cell and gene therapies do not make it all the way to the patients. Researchers and ...
10 x 15 in. (25.4 x 38.1 cm.) Subscribe now to view details for this work, and gain access to over 18 million auction results. Purchase One-Day Pass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results